Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 6237-6243, November 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silvers, K. J.
Right arrow Articles by Howard, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silvers, K. J.
Right arrow Articles by Howard, P. C.

Cytochrome P-450 3A4 (Nifedipine Oxidase) Is Responsible for the C-oxidative Metabolism of 1-Nitropyrene in Human Liver Microsomal Samples1

Kimberly J. Silvers, Tammy Chazinski, Michael E. McManus, Susan L. Bauer, Frank J. Gonzalez, Harry V. Gelboin, Patrick Maurel and Paul C. Howard2

Department of Environmental Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4940 [K. J. S., T. C., S. L. B., P. C. H.]; Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park 5042, South Australia, Australia [M. E. M.]; Laboratory for Molecular Carcinogenesis, NIH, Bethesda, Maryland 20892 [F. J. G., H. V. G.]; and INSERM U 128, CNRS Route de Mende, BP 5051, 34033 Montpellier Cedex, France [P. M.]

The nitrated polycyclic aromatic hydrocarbon 1-nitropyrene is a ubiquitous environmental pollutant. The role of cytochromes P-450 in the human metabolism of [3H]-1-nitropyrene was investigated using human liver microsomes. The range of microsomal metabolism from 16 individual liver specimens was 0.13 to 0.99 nmol/min/mg protein. Using 3 microsomal samples exhibiting different maximal velocities, the Km of 1-nitropyrene metabolism was 3.3 ± 0.5 µM, indicating that perhaps a single or similar cytochromes P-450 was involved in the metabolism of 1-nitropyrene in these samples. The P-450 3A inhibitor triacetylolean-domycin inhibited 86 ± 8% of the microsomal metabolism of 1-nitropyrene. Further evidence for the role of P-450 3A in human microsomal metabolism of 1-nitropyrene was gained using inhibitory anti-P-450 3A antibodies. Using 3 separate microsomal samples, antibody conditions that inhibited approximately 90% of the metabolism of the P-450 3A4-specific substrate nifedipine inhibited approximately 60–70% of the metabolism of 1-nitropyrene. Human liver microsomes demonstrated a preference for 1-nitropyren-3-ol formation over 1-nitropyren-6-ol or 1-nitropyren-8-ol, which is in contrast to that noted in rodents where the 6-ol and 8-ol are preferentially formed over the 3-ol, yet in agreement with earlier studies on the metabolism of 1-nitropyrene using Vaccinia-expressed human cytochromes P-450. These results indicate that the human hepatic metabolism of 1-nitropyrene is carried out by at least two or more P-450s including those in the P-450 3A subfamily. These studies also suggest that the metabolism of this compound by humans may differ from that in rodents in both the cytochromes that are involved and the specific metabolites that are formed.

1 This work was supported in part by Grant ES03648 from the NIH.

2 To whom requests for reprints should be addressed.

Received 5/ 8/92. Accepted 9/11/92.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
A. B. Ulrich, J. Standop, B. M. Schmied, M. B. Schneider, T. A. Lawson, and P. M. Pour
Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas
Toxicol Pathol, February 1, 2002; 30(2): 247 - 253.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ekins, G. Bravi, J. H. Wikel, and S. A. Wrighton
Three-Dimensional-Quantitative Structure Activity Relationship Analysis of Cytochrome P-450 3A4 Substrates
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 424 - 433.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y.-H. Chae, T. Thomas, F. P. Guengerich, P. P. Fu, and K. El-Bayoumy
Comparative Metabolism of 1-, 2-, and 4-Nitropyrene by Human Hepatic and Pulmonary Microsomes
Cancer Res., April 1, 1999; 59(7): 1473 - 1480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.